The second breakout session was directed to attendees in the information technology (IT) and biotechnology sectors, with discussion about the recent Alice v. CLS Bank Supreme Court decision.
On Monday, September 24, Knobbe Martens hosted an IP Impact 2012 seminar at the Four Seasons – Palo Alto. Over 85 attendees enjoyed a special presentation by keynote speaker, Mr. Raymond Chen, Deputy General Counsel and Solicitor at the USPTO. Following a short Q&A session with Mr. Chen, Knobbe Martens attorney Andrew H. Simpson presented on "What You Need to Know About Patent Filing and Litigation in Europe", one of three presentations given during the seminar.
The America Invents Act (AIA), enacted in September 2011, made significant changes to patent law that go into effect September 2012 and March 2013. The U.S. Patent and Trademark Office recently published over a thousand pages of rules dealing with the AIA . View this presentation to learn what hightech companies need to know about the AIA and what you should be doing to implement the right IP strategy at your company.
Our panel of Knobbe Martens partners hosted this complimentary and informative webinar to discuss the state of software and hardware IP protection and enforcement.
Challenges to obtaining broad software and hardware IP protection are coming from every side. The Supreme Court may decide this year whether certain software even qualifies as patentable subject matter. The USPTO is also examining certain types of software applications with higher scrutiny.
Many recent decisions at the Federal Circuit have made it harder to enforce the IP that you do obtain. In addition to those difficulties, pending patent reform legislation may force a “loser pays” approach in court, where a company may have to pay millions of dollars in legal fees if they don’t win their litigation.
Our panel explained these issues, and provided real-world strategies to help maximize the protection and enforcement of your intellectual property.
Partner Michael Guiliana presented on "Best Practices for Employee, Contractor and Consulting Agreements" at the Association of Corporate Counsel - Southern California Chapter "DoubleHeader" event.
Knobbe Martens hosted a Pre-Conference Workshop on Monday, October 15, 2012, at the IN3 Medical Device Summit in San Francisco. Knobbe Partners Paul Conover, Curtis Huffmire, and Karen Vogel Weil presented a “Patent Update for Medical Device Companies.” This forum took place in the hub of device investment and innovation in the San Francisco Bay Area, and brought together a diverse group of medtech’s key thought leaders to candidly discuss the critical issues that will define the future of all players in the evolving device space.
“IP News You Need To Know” featured a discussion of significant recent court decisions and the latest trends from the U.S. Patent Office involving inter partes review (IPR) proceedings and other proceedings.
Knobbe Martens Partner Joseph Re presented at the Washington State Patent Law Association (WSPLA) event "Patent Prosecution Through the Eyes of a Patent Litigator" on Wednesday, September 19, from 12:00 p.m. to 1:30 p.m. View these slides for an in-depth view of patent prosecution and how recent court decisions have impacted IP law.
On Monday, September 24, Knobbe Martens hosted an IP Impact 2012 seminar at the Four Seasons – Palo Alto. Over 85 attendees enjoyed a special presentation by keynote speaker, Mr. Raymond Chen, Deputy General Counsel and Solicitor at the USPTO. Following a short Q&A session with Mr. Chen, Knobbe Martens attorney Andrew H. Simpson presented on "What You Need to Know About Patent Filing and Litigation in Europe", one of three presentations given during the seminar.
The America Invents Act (AIA), enacted in September 2011, made significant changes to patent law that go into effect September 2012 and March 2013. The U.S. Patent and Trademark Office recently published over a thousand pages of rules dealing with the AIA . View this presentation to learn what hightech companies need to know about the AIA and what you should be doing to implement the right IP strategy at your company.
Our panel of Knobbe Martens partners hosted this complimentary and informative webinar to discuss the state of software and hardware IP protection and enforcement.
Challenges to obtaining broad software and hardware IP protection are coming from every side. The Supreme Court may decide this year whether certain software even qualifies as patentable subject matter. The USPTO is also examining certain types of software applications with higher scrutiny.
Many recent decisions at the Federal Circuit have made it harder to enforce the IP that you do obtain. In addition to those difficulties, pending patent reform legislation may force a “loser pays” approach in court, where a company may have to pay millions of dollars in legal fees if they don’t win their litigation.
Our panel explained these issues, and provided real-world strategies to help maximize the protection and enforcement of your intellectual property.
Partner Michael Guiliana presented on "Best Practices for Employee, Contractor and Consulting Agreements" at the Association of Corporate Counsel - Southern California Chapter "DoubleHeader" event.
Knobbe Martens hosted a Pre-Conference Workshop on Monday, October 15, 2012, at the IN3 Medical Device Summit in San Francisco. Knobbe Partners Paul Conover, Curtis Huffmire, and Karen Vogel Weil presented a “Patent Update for Medical Device Companies.” This forum took place in the hub of device investment and innovation in the San Francisco Bay Area, and brought together a diverse group of medtech’s key thought leaders to candidly discuss the critical issues that will define the future of all players in the evolving device space.
“IP News You Need To Know” featured a discussion of significant recent court decisions and the latest trends from the U.S. Patent Office involving inter partes review (IPR) proceedings and other proceedings.
Knobbe Martens Partner Joseph Re presented at the Washington State Patent Law Association (WSPLA) event "Patent Prosecution Through the Eyes of a Patent Litigator" on Wednesday, September 19, from 12:00 p.m. to 1:30 p.m. View these slides for an in-depth view of patent prosecution and how recent court decisions have impacted IP law.
Knobbe Martens’ patent attorneys Russell Jeide and Scott Cromar hosted a seminar series on intellectual property basics for Temecula’s business community. Entrepreneurs, investors, startups, inventors and anyone interested in learning how intellectual property and patents can help their business will benefit from this presentation.
Knobbe Martens' Partners Bil Bunker and Brenden Gingrich presented "Procedures, Pitfalls and Costs: Best Practices for Securing Foreign Patents " at the IP Impact 2012 seminar in McLean, Virginia on Wednesday, May 30, 2012. The seminar was designed for corporate counsel, C-Level executives, venture capitalists, entrepreneurs, IP managers and licensing executives.
In view of the U.S. approval process for biosimilars, companies are gearing up to either produce their own biosimilar products, or to defend against their entry onto the market. While the Biologics Price Competition and Innovation Act (BPCIA) spells out many of the requirements, the pathway for approval is complicated. Our panel of experts discuss the features of the BPCIA and how it operates for both approved biologics as well as biosimilar entrants. They also make some predictions on its impact for life science companies.
The webinar is 60 minutes, complete with Q&A.
Knobbe Martens attorneys Russell Jeide and Scott Cromar presented “Why is Intellectual Property Important?” at a Temecula Valley Entrepreneur’s Exchange (TVE2) event. The presentation was focused on the importance of IP to entrepreneurs and new businesses, and was part of an all-day event celebrating TVE2’s two year anniversary. The event was called “Innovate. Grow. Connect.”
Partner Agnes Juang, Ph.D. presented "Navigating the Patent Minefield" at SABPA's 9th Annual Biomedical Forum on Saturday, April 26, at the Crowne Plaza Hotel in Costa Mesa.
The event showcased a number of experts across the pharmaceutical, medical device, and diagnostics industries.
Knobbe Martens’ patent attorneys Russell Jeide and Scott Cromar hosted a seminar series on intellectual property basics for Temecula’s business community. This presentation walks the viewer through how to file for a patent. Entrepreneurs, investors, startups, inventors and anyone interested in learning how intellectual property and patents can help their business will benefit from this presentation.
On Monday, September 24, Knobbe Martens hosted an IP Impact 2012 seminar at the Four Seasons – Palo Alto. Over 85 attendees enjoyed a special presentation by keynote speaker, Mr. Raymond Chen, Deputy General Counsel and Solicitor at the USPTO. Mr. Chen joined Knobbe Martens attorneys Gerard von Hoffmann, Brent Babcock and Scott Smith and presented on "Dealing Strategically with the America Invents Act", one of three presentations given during the seminar.
The America Invents Act (AIA), enacted in September 2011, made significant changes to patent law that go into effect September 2012 and March 2013. The U.S. Patent and Trademark Office recently published over a thousand pages of rules dealing with the AIA . View this presentation to learn what hightech companies need to know about the AIA and what you should be doing to implement the right IP strategy at your company.
Knobbe Martens’ patent attorneys Russell Jeide and Scott Cromar will host a free seminar series on intellectual property basics for Temecula’s business community. This interactive and practical series will provide a basic overview of patents, copyrights and trademarks, while also answering questions about preparing patent applications and how to file for a patent. Entrepreneurs, investors, startups, inventors and anyone interested in learning how intellectual property and patents can help their business will benefit from these classes.
WHO: Knobbe Martens, one of the largest intellectual property firms in the United States, in conjunction with the Temecula Valley Entrepreneur’s Exchange will host this series.
SPEAKERS: Jeide specializes in several areas of intellectual property law, including patent prosecution, legal opinion work and licensing. Cromar focuses on IP counseling and patent preparation and prosecution.
COST: Classes are free and open to the public. However, seating is limited so please RSVP via the following link: http://tve2ipbasicsseries.eventbrite.com/.
Knobbe Martens' attorneys Brenden Gingrich and Kathleen Mekjian conducted a workshop on Sunday, May 5, 2012 at the 99th Annual Meeting of The American Association of Immunologists (AAI), entitled "Monetizing Your Intellectual Property: Protecting Ideas that Generate Income." This presentation explores the types of research innovations that are protectable and provides practical tips for protecting innovations while avoiding some common pitfalls, which can compromise intellectual property.
Knobbe Martens attorneys Andrew Douglas and Shannon Lam presented "Intellectual Property for Engineers" on January 14, 2014 at the University of California, Irvine.
On Saturday, April 28, 2012, Knobbe Martens Partner Agnes Juang presented "Intellectual Property Considerations During Product Development" at the Sino-American Biomedical & Pharmaceutical Professionals Association (SABPA) 7th Annual Biomedical Forum, which was held at the McDonnell Douglas Engineering Auditorium at UC Irvine.
The Federal Circuit Review is a monthly newsletter featuring the latest case summaries handed down from the U.S. Court of Appeals for the Federal Circuit.
In this issue:
Licensing to Foreign Manufacturers Satisfies Domestic Industry
Appeal Found to Be Moot in Light of “Side Bet”
Mere Design Choice Leads to Obviousness Finding
Design Patent Infringement Complaint Survives Dismissal
A panel presentation discussed the patent litigation story of Santa Clara-based Access Closure and its recent victory against St. Jude Medical. Principals from Access Closure will share the perspective of management of a young but growing company, and how it navigated through potentially devastating patent infringement litigation to a successful exit.
Knobbe Martens’ patent attorneys Russell Jeide and Scott Cromar hosted a seminar series on intellectual property basics for Temecula’s business community. Entrepreneurs, investors, startups, inventors and anyone interested in learning how intellectual property and patents can help their business will benefit from this presentation.
Knobbe Martens' Partners Bil Bunker and Brenden Gingrich presented "Procedures, Pitfalls and Costs: Best Practices for Securing Foreign Patents " at the IP Impact 2012 seminar in McLean, Virginia on Wednesday, May 30, 2012. The seminar was designed for corporate counsel, C-Level executives, venture capitalists, entrepreneurs, IP managers and licensing executives.
In view of the U.S. approval process for biosimilars, companies are gearing up to either produce their own biosimilar products, or to defend against their entry onto the market. While the Biologics Price Competition and Innovation Act (BPCIA) spells out many of the requirements, the pathway for approval is complicated. Our panel of experts discuss the features of the BPCIA and how it operates for both approved biologics as well as biosimilar entrants. They also make some predictions on its impact for life science companies.
The webinar is 60 minutes, complete with Q&A.
Knobbe Martens attorneys Russell Jeide and Scott Cromar presented “Why is Intellectual Property Important?” at a Temecula Valley Entrepreneur’s Exchange (TVE2) event. The presentation was focused on the importance of IP to entrepreneurs and new businesses, and was part of an all-day event celebrating TVE2’s two year anniversary. The event was called “Innovate. Grow. Connect.”
Partner Agnes Juang, Ph.D. presented "Navigating the Patent Minefield" at SABPA's 9th Annual Biomedical Forum on Saturday, April 26, at the Crowne Plaza Hotel in Costa Mesa.
The event showcased a number of experts across the pharmaceutical, medical device, and diagnostics industries.
Knobbe Martens’ patent attorneys Russell Jeide and Scott Cromar hosted a seminar series on intellectual property basics for Temecula’s business community. This presentation walks the viewer through how to file for a patent. Entrepreneurs, investors, startups, inventors and anyone interested in learning how intellectual property and patents can help their business will benefit from this presentation.
On Monday, September 24, Knobbe Martens hosted an IP Impact 2012 seminar at the Four Seasons – Palo Alto. Over 85 attendees enjoyed a special presentation by keynote speaker, Mr. Raymond Chen, Deputy General Counsel and Solicitor at the USPTO. Mr. Chen joined Knobbe Martens attorneys Gerard von Hoffmann, Brent Babcock and Scott Smith and presented on "Dealing Strategically with the America Invents Act", one of three presentations given during the seminar.
The America Invents Act (AIA), enacted in September 2011, made significant changes to patent law that go into effect September 2012 and March 2013. The U.S. Patent and Trademark Office recently published over a thousand pages of rules dealing with the AIA . View this presentation to learn what hightech companies need to know about the AIA and what you should be doing to implement the right IP strategy at your company.
Knobbe Martens’ patent attorneys Russell Jeide and Scott Cromar will host a free seminar series on intellectual property basics for Temecula’s business community. This interactive and practical series will provide a basic overview of patents, copyrights and trademarks, while also answering questions about preparing patent applications and how to file for a patent. Entrepreneurs, investors, startups, inventors and anyone interested in learning how intellectual property and patents can help their business will benefit from these classes.
WHO: Knobbe Martens, one of the largest intellectual property firms in the United States, in conjunction with the Temecula Valley Entrepreneur’s Exchange will host this series.
SPEAKERS: Jeide specializes in several areas of intellectual property law, including patent prosecution, legal opinion work and licensing. Cromar focuses on IP counseling and patent preparation and prosecution.
COST: Classes are free and open to the public. However, seating is limited so please RSVP via the following link: http://tve2ipbasicsseries.eventbrite.com/.
Knobbe Martens' attorneys Brenden Gingrich and Kathleen Mekjian conducted a workshop on Sunday, May 5, 2012 at the 99th Annual Meeting of The American Association of Immunologists (AAI), entitled "Monetizing Your Intellectual Property: Protecting Ideas that Generate Income." This presentation explores the types of research innovations that are protectable and provides practical tips for protecting innovations while avoiding some common pitfalls, which can compromise intellectual property.
Knobbe Martens attorneys Andrew Douglas and Shannon Lam presented "Intellectual Property for Engineers" on January 14, 2014 at the University of California, Irvine.
On Saturday, April 28, 2012, Knobbe Martens Partner Agnes Juang presented "Intellectual Property Considerations During Product Development" at the Sino-American Biomedical & Pharmaceutical Professionals Association (SABPA) 7th Annual Biomedical Forum, which was held at the McDonnell Douglas Engineering Auditorium at UC Irvine.
The Federal Circuit Review is a monthly newsletter featuring the latest case summaries handed down from the U.S. Court of Appeals for the Federal Circuit.
In this issue:
Licensing to Foreign Manufacturers Satisfies Domestic Industry
Appeal Found to Be Moot in Light of “Side Bet”
Mere Design Choice Leads to Obviousness Finding
Design Patent Infringement Complaint Survives Dismissal
A panel presentation discussed the patent litigation story of Santa Clara-based Access Closure and its recent victory against St. Jude Medical. Principals from Access Closure will share the perspective of management of a young but growing company, and how it navigated through potentially devastating patent infringement litigation to a successful exit.
This presentation addresses the why, what, and how to protect inventions from the vantage point of the early-stage, pre-financing, start-up company that is interested in patenting its inventions and developing an intellectual property portfolio that maximizes the company's valuation and sets it up for success during the intellectual property due diligence that accompanies financing rounds, corporate partnerships, commercialization, and merger and acquisition.
Biotechnology Patents: Disclosure Requirements under 35 USC 112. Discusses case law development of the enablement and written description requirements from In re Wright (Fed. Cir. 1993) through Ariad Pharmaceuticals v. Eli Lilly (Fed. Cir. 2010), including the origin of the "super enablement" requirement in Regents of the University of California v. Eli Lilly (Fed. Cir. 1997), the thought provoking dissent by Chief Judge Rader in Enzo Biochem v. Gen-Probe (Fed. Cir. 2002), the paradoxical "nascent technology" holding in Chiron v. Genentech (Fed. Cir. 2004), and the risks of relying on functional claim language from Rochester v. Searle (Fed. Cir. 2004). Practice tips are provided for avoiding the pitfalls in patent and claim drafting in view of these seminal cases.
Biotechnology Patents: Utility and eligibility requirements under 35 USC 101. This presentation follows the historical development of the utility requirement from the early 19th century case Lowell v. Lewis (MA 1817), the origin of the specific, substantial, and credible standard for a patent disclosure from Brenner v. Manson (SCOTUS 1966), and the modern application of the Brenner standard for biotechnology patents in In re Fisher (Fed. Cir. 2005). Biotechnology eligibility requirements are discussed from the early Supreme Court case Funk Brothers v. Kalo, the seminal biotechnology Supreme Court case Diamond v. Chakrabarty (SCOTUS 1980) where the court holds that statutory subject matter includes "anything under the sun that is made by man," through the recent Supreme Court decision in Myriad v. ACLU (SCOTUS 2013) where the court held that diagnostic method claims and nucleic acid claims that read on products of nature are patent inelibible. Practice tips are provided to ensure that patent claims avoid the exceptions of 35 USC 101 and withstand scrutiny during litigation and business transactions, such as licensing.
Maximizing Pharmaceutical Patent Life Cycles: Strategies to Avoid Obviousness...Rachel Hamilton
For over a decade, American Conference Institute’s (ACI’s) Maximizing Pharmaceutical Patent Life Cycles and Biotech Patents conferences have brought you up-to –the minute legal, regulatory, and policy information concerning small and large molecule drug products. In deference to the legacy of these iconic events and your revered opinion, ACI proudly presents this new program on Pharmaceutical and Biotechnology Patent Life Cycles and Portfolio Strategies. This conference will give you a comprehensive and thorough picture of how small and large molecule products—as well as diagnostics—operate in a world not only governed by PTO and FDA-related laws and regulations, but also against the backdrop of Hatch-Waxman, BPCIA, iconoclast Supreme Court decisions affecting the future life sciences IP, and Health Care Reform. Our stellar faculty will provide you with insights and strategies relative to life cycle management, portfolio strategies, brand optimization and new product development as well as the thoughtful and targeted commentary and in-depth analysis that you have come to expect from ACI’s industry-leading life sciences IP conferences.
This presentation discusses the historical context for the recent court decisions that affect the patent eligibility of biotechnology inventions, including those directed to genes, cDNAs, proteins, antibodies, and diagnostic methods. Discussed are the early Funk Brothers and Chakrabarty decisions as well as the Lab Corp, Bilski, Prometheus, Classen, and Myriad court opinions. The impact of the court holdings on the future development of biotechnology inventions, in particular personalized medicine inventions, is analyzed as is the erosion of the requisite incentives of innovative companies to invent and commercialize in areas where patent protection is less certain.
July’s practice group lunch included an overview of recent decisions, the Court of Appeals for the Federal Circuit, and the United States Supreme Court. The Supreme Court addressed a number of patent law topics this year, including the standard of review for patent claim construction (Teva Pharmaceuticals v. Sandoz), royalties on expired patents (Kimble v. Marvel Enterprises), and defenses to claims of induced infringement (Commil v. Cisco). The initial wave of appeals in post-issuance proceedings provided by the America Invents Act are now being decided by the Federal Circuit. These include cases involving whether the decision to institute is reviewable (In re Cuozzo Speed Technologies) and discussion of the claim construction standards that apply (Microsoft v. Proxyconn). The relationship between administrative challenges and related litigation is also an evolving area (ePlus v. Lawson Software).
Monoclonal Antibodies Dawn Of A New EraWouter Pors
Seminar on IP and regulatory aspects, Brussels, 7 June 2012, speakers Michael Alt, Trevor Cook, Liz Fuller, Marc Martens (Bird & Bird) and Frank Landolt (Ablynx)
This analysis shows how IP, regulatory, and marketing strategy have to interfere for maximizing the lifetime of IP protection in pharmaceuticals. In contrast to mechanical inventions you can use special aspects of chemical /pharmaceutical patents like medical use or SPCs and PTE or variations in formulation to optimize your product protection. Using the example of an active ingredient it is shown how filing strategy, product development and finally IP life cycle management can be combined to achieve the maximum market success.
Our panel discussed the state of software patent eligibility after Alice Corp v. CLS Bank International in a recent webinar.
Since the Supreme Court's decision last year in Alice v. CLS Bank, business method and software-based patents have been invalidated at an alarming pace. The basis for invalidation has been "ineligible" subject matter under 35 USC § 101, despite the fact that the Supreme Court clearly stated that such software inventions were not per se unpatentable. This phenomenon has resulted in an "analysis paralysis" in the PTO which has brought new business method and software-based patent issuance to a virtual standstill. Recently, however, Knobbe Martens software prosecution teams have found success in overcoming § 101 rejections by PTO examiners.
Topics include:
- Aligning patent filing strategies with the company’s business goals
- Understanding the importance of the initial disclosure
- Analyzing PTO methods and processes in classifying and assigning applications for examination
- Preparing the application to focus on technical innovations and not business methods
- Developing claim strategies that satisfy § 101
- Interviewing and expediting prosecution to overcome § 101 rejections and push to issuance
- Using issued software patents to further short and long term competitive strategies
Topics covered in this month’s patent group presentation include information about the current backlog of patent applications at the United States Patent and Trademark Office (USPTO), new rules regarding derivation proceedings, a practice tip for releasing search results to the European Patent Office, proposed USPTO ethics rules codifying with the ABA rules, patentability of computer software, and recent cases about inter partes reexamination.
Attorneys Mauricio Uribe, Eric Forman and Vlad Teplitskiy present a Webinar focusing on strategic considerations for patent prosecution in the United States in view of the statutory requirements of Section 103.
Attorney Mauricio Uribe, Michael Guiliana and Of Counsel Hironori Kubota present a Webinar focusing on strategic considerations for patent prosecution in the United States in view of the statutory requirements of Section 103. Leveraging years of focused prosecution practice, Knobbe Martens practitioners will provide insights related to the statutory requirements and best practices for effective prosecution.
Slides from Tim Haley\'s October 6, 2011 web event - ASTM\'s New E2790 Continuing Obligations Standard: What It Means for You. To watch a replay visit our website. http://commonground.edrnet.com/pages/ead25677de
Paul Conover, Curtis Huffmire and Brent Babcock recently presented at the IN3 Medical Device Summit conference in San Francisco, CA. This presentation covers: recent patent cases from the supreme court, medical device patent statistics and cases, and USPTO Post-Grant Proceedings lessons learned after two years.
On October 23, 2013, Knobbe Martens Partners Andrew Douglas and Sabing Lee presented on "Preparing Your Medical Device NewCo for IP Due Diligence" at the OCTANe Medical Device and Investor Forum.
Power Point Presentation describing new laws and rules governing patentable subject matter in the U.S., particularly in the biotechnology and pharmaceutical industries
Knobbe Martens' Partner Brenden Gingrich presented "Patenting the Unpatentable - Claim Drafting After Prometheus" at the IP Impact 2012 seminar in McLean, Virginia on Wednesday, May 30, 2012. The seminar was designed for corporate counsel, C-Level executives, venture capitalists, entrepreneurs, IP managers and licensing executives.
Common Pitfalls and Key Considerations in Getting (and Keeping) Intellectual ...UCICove
About UCI Applied Innovation:
UCI Applied Innovation is a dynamic, innovative central platform for the UCI campus, entrepreneurs, inventors, the business community and investors to collaborate and move UCI research from lab to market.
About the Cove @ UCI:
To accelerate collaboration by better connecting innovation partners in Orange County, UCI Applied Innovation created the Cove, a physical, state-of-the-art hub for entrepreneurs to gather and navigate the resources available both on and off campus. The Cove is headquarters for UCI Applied Innovation, as well as houses several ecosystem partners including incubators, accelerators, angel investors, venture capitalists, mentors and legal experts.
Follow us on social media:
Facebook: @UCICove
Twitter: @UCICove
Instagram: @UCICove
LinkedIn: @UCIAppliedInnovation
For more information:
cove@uci.edu
http://innovation.uci.edu/
Partner Ben Anger discusses the latest developments and advanced strategies for PTAB practice, specifically focused on the petitioner side. Ben covers issues related to selecting the prior art, anticipation versus single-reference obviousness, motivation to combine, post-institution practice, and more.
Webcast Slides--Gibson Dunn 2012 Year-End Report and Hot TopicsGareth Evans
These are the slides from our Webcast on the Gibson Dunn 2012 E-Discovery Year-End Report. Watch for our 2013 Mid-Year E-Discovery Report around the end of June.
Partners Susan Natland and Jessica Sganga discussed potential trademark and copyright issues in the emerging metaverse, including the surge in popularity of NFTs (non-fungible tokens) and how they may affect intellectual property protections. Get up-to-speed on the “hot” cases in this evolving area and get practical tips on how best to protect your intellectual property from infringement in this virtual space.
Speakers: Susan Natland, Jessica Sganga
Knobbe partners Jeff Van Hoosear (OC) Jason Jardine (SD) and associate Julia Hanson (SD) recently gave a presentation at San Diego Fashion week on intellectual property for designers and artists. The presentation explored what IP is, why it is important to designers, top 5 misconceptions, how to get a copyright, how to get a trademark and how to get a design patent.
Partner Mauricio Uribe continued the two-part, comprehensive discussion on responding to IP threats and assertions. The presentation focused on a more detailed exploration of the topic and strategic implications for various scenarios.
Speakers: Mauricio Uribe
Partners Melanie Seelig and Mauricio Uribe kicked off a two-part, comprehensive discussion on responding to IP threats and assertions. The presentation served as an introduction to the topic and provided more general information.
Speakers: Melanie Seelig and Mauricio Uribe
Partner Mauricio Uribe continued the two-part, comprehensive discussion on open-source software and third-party vendors. The presentation focused on a more detailed exploration of the topic and strategic implications for various scenarios.
Speakers: Mauricio Uribe
Partner Jason Gersting, Ph.D. moderated a panel of his peers in a discussion about learning how to identify the waves in current written description and enablement law and tips for smoothly riding them to expand, enhance and protect life sciences intellectual property rights. Panelists included Knobbe Martens partners Jessica Achtsam, Eric Furman, Ph.D., and Dan Altman.
Partner Mauricio Uribe kicked off a two-part, comprehensive discussion on open-source software and third-party vendors. The presentation served as an introduction to the topic and provided more general information.
Speakers: Mauricio Uribe
Partner Mauricio Uribe continued the two-part, comprehensive discussion on data privacy. The presentation focused on a more detailed exploration of the topic and strategic implications for various scenarios .
Speakers: Mauricio Uribe
Partner Mauricio Uribe kicked off a two-part, comprehensive discussion on data privacy. The presentation served as an introduction to the topic and provided more general information.
Speakers: Mauricio Uribe
Partners Mauricio Uribe and Vlad Lozan gave an informative presentation on design patent law in the United States. The partners provided best practices for filing and prosecuting design patents in the U.S. and techniques and strategies for including multiple design embodiments in design patent applications. They also discussed how to identify and protect visual elements in computer-related technologies and how to integrate design patents into a holistic intellectual property strategy.
Speakers: Mauricio Uribe, Vlad Lozan
Partners Melanie Seelig and Mauricio Uribe continued the two-part, comprehensive discussion on trade secrets. The presentation focused on a more detailed exploration of the topic and strategic implications for various scenarios .
Speakers: Melanie Seelig and Mauricio Uribe
Partners Melanie Seelig and Mauricio Uribe kicked off a two-part, comprehensive discussion on trade secrets. The presentation served as an introduction to the topic and provided more general information.
Speakers: Melanie Seelig and Mauricio Uribe
Partners Mauricio Uribe and Paul Stellman continued the two-part, comprehensive discussion of strategic planning for capturing and protecting intellectual property. The presentation focused on a more detailed exploration of the topic, diving into the best intellectual property portfolios and cost deferrable strategies to maximize intellectual property spend.
Speakers: Mauricio Uribe and Paul Stellmann
Partners Mauricio Uribe and Vlad Teplitskiy gave an informative presentation on strategic considerations for claim drafting electrical and telecommunications Inventions. The partners provided illustrative claim drafting examples and best practices for defining claim scope, as well as claim drafting strategies for avoiding or minimizing unintentional functional claiming.
Speakers: Mauricio Uribe, Vlad Teplitskiy
Partners Maria Stout and Paul Stellman kicked off a two-part, comprehensive discussion of strategic planning for capturing and protecting intellectual property. The presentation served as an introduction to the topic and provided more general information.
Speakers: Maria Stout and Paul Stellmann
Partners Melanie Seelig and Mauricio Uribe continued the two-part, comprehensive discussion of strategic considerations regarding employment and vendor agreements. The presentation focused on a more detailed exploration of managing employment and vendor agreements, follow-on agreements, and sample language and practical examples.
Speakers: Melanie Seelig and Mauricio Uribe
Partners Melanie Seelig and Maria Stout kicked off a two-part, comprehensive discussion of strategic intellectual property considerations regarding employment and vendor agreements. This presentation served as an introduction to the topic and provided more general information.
Speakers: Melanie Seelig and Maria Stout
Knobbe Practice Japan Webinar Series
Partner Mauricio Uribe provided a detailed discussion focused on advanced patent claim drafting techniques for artificial intelligence technologies and related applications. The discussion covered: claim drafting techniques to capture different aspects of artificial intelligence/machine learning technologies; considerations for detecting infringement and possible alternative trade secret protection in the United States; and considerations for patent subject matter eligibility under Section 101.
This was the second and more advanced part of the webinar on understanding and protecting artificial intelligence and machine learning technologies. If you missed the introductory webinar on this topic, you can view the recording here.
Speakers: Mauricio Uribe and Kenny Masaki
Partners Paul Stellman and Jessica Achtsam continued the two-part, comprehensive discussion of strategic considerations regarding non-disclosure agreements and confidentiality policies. The presentation focused on a more detailed exploration of non-disclosure agreements and strategic implications for various scenarios.
Speakers: Paul Stellman and Jessica Achtsam
More from Knobbe Martens - Intellectual Property Law (20)
PRECEDENT AS A SOURCE OF LAW (SAIF JAVED).pptxOmGod1
Precedent, or stare decisis, is a cornerstone of common law systems where past judicial decisions guide future cases, ensuring consistency and predictability in the legal system. Binding precedents from higher courts must be followed by lower courts, while persuasive precedents may influence but are not obligatory. This principle promotes fairness and efficiency, allowing for the evolution of the law as higher courts can overrule outdated decisions. Despite criticisms of rigidity and complexity, precedent ensures similar cases are treated alike, balancing stability with flexibility in judicial decision-making.
Military Commissions details LtCol Thomas Jasper as Detailed Defense CounselThomas (Tom) Jasper
Military Commissions Trial Judiciary, Guantanamo Bay, Cuba. Notice of the Chief Defense Counsel's detailing of LtCol Thomas F. Jasper, Jr. USMC, as Detailed Defense Counsel for Abd Al Hadi Al-Iraqi on 6 August 2014 in the case of United States v. Hadi al Iraqi (10026)
Car Accident Injury Do I Have a Case....Knowyourright
Every year, thousands of Minnesotans are injured in car accidents. These injuries can be severe – even life-changing. Under Minnesota law, you can pursue compensation through a personal injury lawsuit.
WINDING UP of COMPANY, Modes of DissolutionKHURRAMWALI
Winding up, also known as liquidation, refers to the legal and financial process of dissolving a company. It involves ceasing operations, selling assets, settling debts, and ultimately removing the company from the official business registry.
Here's a breakdown of the key aspects of winding up:
Reasons for Winding Up:
Insolvency: This is the most common reason, where the company cannot pay its debts. Creditors may initiate a compulsory winding up to recover their dues.
Voluntary Closure: The owners may decide to close the company due to reasons like reaching business goals, facing losses, or merging with another company.
Deadlock: If shareholders or directors cannot agree on how to run the company, a court may order a winding up.
Types of Winding Up:
Voluntary Winding Up: This is initiated by the company's shareholders through a resolution passed by a majority vote. There are two main types:
Members' Voluntary Winding Up: The company is solvent (has enough assets to pay off its debts) and shareholders will receive any remaining assets after debts are settled.
Creditors' Voluntary Winding Up: The company is insolvent and creditors will be prioritized in receiving payment from the sale of assets.
Compulsory Winding Up: This is initiated by a court order, typically at the request of creditors, government agencies, or even by the company itself if it's insolvent.
Process of Winding Up:
Appointment of Liquidator: A qualified professional is appointed to oversee the winding-up process. They are responsible for selling assets, paying off debts, and distributing any remaining funds.
Cease Trading: The company stops its regular business operations.
Notification of Creditors: Creditors are informed about the winding up and invited to submit their claims.
Sale of Assets: The company's assets are sold to generate cash to pay off creditors.
Payment of Debts: Creditors are paid according to a set order of priority, with secured creditors receiving payment before unsecured creditors.
Distribution to Shareholders: If there are any remaining funds after all debts are settled, they are distributed to shareholders according to their ownership stake.
Dissolution: Once all claims are settled and distributions made, the company is officially dissolved and removed from the business register.
Impact of Winding Up:
Employees: Employees will likely lose their jobs during the winding-up process.
Creditors: Creditors may not recover their debts in full, especially if the company is insolvent.
Shareholders: Shareholders may not receive any payout if the company's debts exceed its assets.
Winding up is a complex legal and financial process that can have significant consequences for all parties involved. It's important to seek professional legal and financial advice when considering winding up a company.
A "File Trademark" is a legal term referring to the registration of a unique symbol, logo, or name used to identify and distinguish products or services. This process provides legal protection, granting exclusive rights to the trademark owner, and helps prevent unauthorized use by competitors.
Visit Now: https://www.tumblr.com/trademark-quick/751620857551634432/ensure-legal-protection-file-your-trademark-with?source=share
DNA Testing in Civil and Criminal Matters.pptxpatrons legal
Get insights into DNA testing and its application in civil and criminal matters. Find out how it contributes to fair and accurate legal proceedings. For more information: https://www.patronslegal.com/criminal-litigation.html
ASHWINI KUMAR UPADHYAY v/s Union of India.pptxshweeta209
transfer of the P.I.L filed by lawyer Ashwini Kumar Upadhyay in Delhi High Court to Supreme Court.
on the issue of UNIFORM MARRIAGE AGE of men and women.
How to Obtain Permanent Residency in the NetherlandsBridgeWest.eu
You can rely on our assistance if you are ready to apply for permanent residency. Find out more at: https://immigration-netherlands.com/obtain-a-permanent-residence-permit-in-the-netherlands/.
NATURE, ORIGIN AND DEVELOPMENT OF INTERNATIONAL LAW.pptxanvithaav
These slides helps the student of international law to understand what is the nature of international law? and how international law was originated and developed?.
The slides was well structured along with the highlighted points for better understanding .
Introducing New Government Regulation on Toll Road.pdfAHRP Law Firm
For nearly two decades, Government Regulation Number 15 of 2005 on Toll Roads ("GR No. 15/2005") has served as the cornerstone of toll road legislation. However, with the emergence of various new developments and legal requirements, the Government has enacted Government Regulation Number 23 of 2024 on Toll Roads to replace GR No. 15/2005. This new regulation introduces several provisions impacting toll business entities and toll road users. Find out more out insights about this topic in our Legal Brief publication.
Introducing New Government Regulation on Toll Road.pdf
Information Technology/Biotechnology
1. knobbe.com
Information Technology and Biotechnology Breakout Session:
New Pieces to the Patent Puzzle
Maria Anderson
Rose Thiessen
Eli Loots
November 6, 2014
IP Impact, Silicon Valley
31. knobbe.com
Orange County
San Diego
San Francisco
Silicon Valley
Los Angeles
Seattle
Washington DC
Maria.Anderson@knobbe.com
Rose.Thiessen@knobbe.com
Eli.Loots@knobbe.com
Maria Anderson
Rose Thiessen
Eli Loots
Thank You